用口服托法西提尼布有效治疗 Prurigo Nodularis:一个案例报告
相关实验视频
Updated: May 23, 2025

08:36
Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3
Published on: April 7, 2023
944
1Skin Research Center Shahid Beheshti University of Medical Sciences Tehran Iran.
Clinical case reports
|March 7, 2025
概括
新的研究表明,雅努斯酶 (JAK) 抑制剂可以有效治疗结节炎 (PN). 这项案例研究强调托法西提尼布作为耐火性PN的成功治疗方法,为这种慢性皮肤病患者提供了希望.
科学领域:
- 皮肤病学 皮肤病学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 发结节 (PN) 是一种慢性炎症性皮肤疾病,其特征是强烈的和结节性病变.
- 最近对PN病变的理解指出了特定的免疫路径,建议针对性治疗.
研究的目的:
- 评估Janus激酶 (JAK) 抑制剂在治疗耐火性prurigo nodularis中的疗效.
- 介绍一个用tofacitinib成功治疗PN的案例研究.
主要方法:
- 关于PN病原和JAK抑制机制的文献综述.
- 一个患有耐火性PN的患者的临床病例陈述.
主要成果:
- 新出现的证据支持JAK抑制剂作为对形和非形PN的潜在治疗方法.
- 托法西替尼在耐火性PN病例中表现出成功的治疗结果.
结论:
- 包括托法西提尼布在内的JAK抑制剂是治疗结节炎的一个有前途的治疗途径.
- 向疗法为难以治疗的PN患者提供了新的希望.
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
107
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
107
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
130
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
130
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
92
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
92
Tumor Immunotherapy
457
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
457
Skin Cancer
3.0K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
3.0K

